Protein Official symbol | CA9 |
Aliases | CA9 G250 MN |
Chromosomal Location | 9 |
Length | 459 |
Uniprot ID | Q16790 |
EC number | 4.2.1.1 |
Protein family Information(Pfam) | PF00194; |
PDB id | 2HKF;3IAI;5DVX;5FL4;5FL5;5FL6;6FE0;6FE1;6FE2;6G98;6G9U;6QN2;6QN5;6QN6;6QUT;6RQN;6RQQ;6RQU;6RQW; |
InterPro ID | IPR018429;IPR001148;IPR036398;IPR023561;IPR018338; |
dbSNP | rs2071676 rs3829078 |
Protein 1 | Protein 2 | Combine Score |
---|---|---|
EP300 | CREBBP | 0.984 |
HIF1A | CA9 | 0.983 |
CA9 | EPAS1 | 0.969 |
HIF1A | EP300 | 0.96 |
ARNT | EP300 | 0.951 |
HIF1A | CREBBP | 0.945 |
CA9 | HIF3A | 0.944 |
CA9 | ARNT | 0.943 |
HIF1A | ARNT | 0.94 |
ARNT | CREBBP | 0.936 |
ARNT | EPAS1 | 0.936 |
EPAS1 | EP300 | 0.934 |
CA9 | EP300 | 0.93 |
HIF3A | ARNT | 0.926 |
EPAS1 | CREBBP | 0.919 |
HIF3A | EP300 | 0.915 |
CA9 | CREBBP | 0.914 |
HIF3A | EPAS1 | 0.908 |
HIF3A | CREBBP | 0.907 |
HIF1A | EPAS1 | 0.907 |
HIF1A | HIF3A | 0.906 |
# | 2033 (EP300) | 3091 (HIF1A) | 768 (CA9) | 405 (ARNT) | 2034 (EPAS1) | 64344 (HIF3A) | 1387 (CREBBP) |
---|---|---|---|---|---|---|---|
2033 (EP300) | 1.00 | 0.56 | 0.42 | 0.52 | 0.55 | 0.21 | 0.79 |
3091 (HIF1A) | 0.56 | 1.00 | 0.58 | 0.86 | 0.89 | 1.00 | 0.70 |
768 (CA9) | 0.42 | 0.58 | 1.00 | 0.49 | 0.59 | 0.21 | 0.45 |
405 (ARNT) | 0.52 | 0.86 | 0.49 | 1.00 | 0.89 | 1.00 | 0.68 |
2034 (EPAS1) | 0.55 | 0.89 | 0.59 | 0.89 | 1.00 | 1.00 | 0.67 |
64344 (HIF3A) | 0.21 | 1.00 | 0.21 | 1.00 | 1.00 | 1.00 | 0.82 |
1387 (CREBBP) | 0.79 | 0.70 | 0.45 | 0.68 | 0.67 | 0.82 | 1.00 |
Protein Official symbol | Source Organism | Tissue of Expression | Level of hypoxia | Altitude | Duration of experiment | Level of expression | Fold change | Experiment details | geographical location | ethnicity of the patients | Control group | Control (Fold change) | Reference (PMID) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CA9 | Mice | Blood | 8% Oxygen | 7600 m | 24 hours | upregulated | 7.2 | RT-qPCR | Western US | C57BL/6 mice | –3.7 | 7600m mice(8% oxygen with Fenofibrate injections Vs Baseline normoxia mice (21% oxygen) | 24183776 |
CA9 | Mice | Blood | 8% Oxygen | 7600 m | 24 hours | upregulated | 8.3 | RT-qPCR | Western US | C57BL/6 mice | –3.7 | 7600m mice(8% oxygen with no Fenofibrate injections Vs Baseline normoxia mice (21% oxygen) | 24183776 |
TF | TF Entrez | Gene | Gene Entrez | Type | PMID | Database |
---|---|---|---|---|---|---|
CTCF | 10664 | CA9 | 768 | distal | 22955619 | TRANSFAC |
NR3C1 | 2908 | CA9 | 768 | proximal_filtered | 22955619 | TRANSFAC |
AHR | 196 | CA9 | 768 | Activation | 21132541 | TRUSST |
ATF4 | 468 | CA9 | 768 | Unknown | 21866569 | TRUSST |
SP1 | 6667 | CA9 | 768 | Unknown | 11278818 | TRUSST |
VHL | 7428 | CA9 | 768 | Activation | 21964930 | TRUSST |
EP300 | 2033 | CA9 | 768 | Unknown | 22102412 | TRUSST |
EPAS1 | 2034 | CA9 | 768 | Unknown | 9265625 | TRUSST |
HDAC4 | 9759 | CA9 | 768 | Repression | 9303434 | TRUSST |
ARNT | 405 | CA9 | 768 | Activation | 22169226 | TRUSST |
ETS1 | 2113 | CA9 | 768 | Repression | 10569470 | TRUSST |
SP3 | 6670 | CA9 | 768 | Unknown | 11278818 | TRUSST |
HIF1A | 3091 | CA9 | 768 | Activation | 9113387 | TRUSST |
miRTarBase ID | miRNA | Species (miRNA) | Protein Official Symbol | Human Entrez ID | Species (Target Gene) | Experiments | Support Type | References (PMID) |
---|---|---|---|---|---|---|---|---|
MIRT027439 | hsa-miR-98-5p | Homo sapiens | CA9 | 768 | Homo sapiens | Microarray | Functional MTI (Weak) | 19088304 |
MIRT028954 | hsa-miR-26b-5p | Homo sapiens | CA9 | 768 | Homo sapiens | Microarray | Functional MTI (Weak) | 19088304 |
ID | GO ID | GO Term | GO Type |
---|---|---|---|
768 | GO:0005886 | plasma membrane | GOTERM_CC_DIRECT |
768 | GO:0001666 | response to hypoxia | GOTERM_BP_DIRECT |
768 | GO:0006730 | one-carbon metabolic process | GOTERM_BP_DIRECT |
768 | GO:0002009 | morphogenesis of an epithelium | GOTERM_BP_DIRECT |
768 | GO:0033574 | response to testosterone | GOTERM_BP_DIRECT |
768 | GO:0004089 | carbonate dehydratase activity | GOTERM_MF_DIRECT |
768 | GO:0008270 | zinc ion binding | GOTERM_MF_DIRECT |
768 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | GOTERM_BP_DIRECT |
768 | GO:0042493 | response to drug | GOTERM_BP_DIRECT |
768 | GO:0016021 | integral component of membrane | GOTERM_CC_DIRECT |
768 | GO:0016323 | basolateral plasma membrane | GOTERM_CC_DIRECT |
768 | GO:0015701 | bicarbonate transport | GOTERM_BP_DIRECT |
768 | GO:0005730 | nucleolus | GOTERM_CC_DIRECT |
768 | GO:0031528 | microvillus membrane | GOTERM_CC_DIRECT |
768 | GO:0046903 | secretion | GOTERM_BP_DIRECT |
Human Entrez ID | KEGG ID | KEGG Term |
---|---|---|
768 | hsa00910 | Nitrogen metabolism |
Protein Official Symbol | Human Entrez ID | Disease Name | Disease Id | Disease Semantic Type | Semantic score | DSI | DPI | Disease Type |
---|---|---|---|---|---|---|---|---|
CA9 | 768 | Anaplasia | C0002793 | Neoplastic Process | 0.3 | 0.537 | 0.586 | disease |
CA9 | 768 | Hypoxia | C0242184 | Pathologic Function | 0.3 | 0.537 | 0.586 | phenotype |
CA9 | 768 | Hypoxemia | C0700292 | Finding | 0.3 | 0.537 | 0.586 | phenotype |
CA9 | 768 | Ductal Carcinoma | C1176475 | Neoplastic Process | 0.32 | 0.537 | 0.586 | disease |
CA9 | 768 | Noninfiltrating Intraductal Carcinoma | C0007124 | Neoplastic Process | 0.32 | 0.537 | 0.586 | disease |
CA9 | 768 | Anoxia | C0003130 | Pathologic Function | 0.4 | 0.537 | 0.586 | phenotype |
CA9 | 768 | Atypical Ductal Breast Hyperplasia | C1332347 | Neoplastic Process | 0.3 | 0.537 | 0.586 | disease |
CA9 | 768 | Myeloid Leukemia, Chronic | C0023473 | Neoplastic Process | 0.31 | 0.537 | 0.586 | disease |
CA9 | 768 | Anoxemia | C0003129 | Sign or Symptom | 0.3 | 0.537 | 0.586 | phenotype |
CA9 | 768 | Pulmonary Hypertension | C0020542 | Pathologic Function | 0.3 | 0.537 | 0.586 | phenotype |
Protein Official Symbol | Human Entrez ID | drug_claim_primary_name | drug_name | drug_chembl_id | interaction_types |
---|---|---|---|---|---|
CA9 | 768 | CG250 177LU | CG250 177LU | CHEMBL3707297 | None |
CA9 | 768 | CG250 111IN | CG250 111IN | CHEMBL3707280 | None |
CA9 | 768 | ETHOXZOLAMIDE | ETHOXZOLAMIDE | CHEMBL18 | inhibitor |
CA9 | 768 | GIRENTUXIMAB | GIRENTUXIMAB | CHEMBL1743027 | None |
CA9 | 768 | IODINE I 124 GIRENTUXIMAB | IODINE I 124 GIRENTUXIMAB | CHEMBL2108713 | None |
CA9 | 768 | Sunitinib | SUNITINIB | CHEMBL535 | None |